These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3001562

  • 1. Evidence against a self-inhibition of ACTH secretion in man.
    Cavagnini F, Invitti C, Danesi L, Passamonti M, Fossati R.
    Neuroendocrinology; 1985 Dec; 41(6):518-25. PubMed ID: 3001562
    [Abstract] [Full Text] [Related]

  • 2. Evidence for ultra-short loop autoregulation of adrenocorticotropin secretion in man.
    Boscaro M, Sonino N, Paoletta A, Rampazzo A, Mantero F.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):255-7. PubMed ID: 2828404
    [Abstract] [Full Text] [Related]

  • 3. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 4. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of pituitary beta-endorphin by ACTH and glucocorticoids.
    Boscaro M, Paoletta A, Giacomazzi P, Fallo F, Sonino N.
    Neuroendocrinology; 1990 May; 51(5):561-4. PubMed ID: 2162013
    [Abstract] [Full Text] [Related]

  • 6. Responsiveness of hypophyseal-adrenocortical axis to repetitive administration of synthetic ovine corticotropin-releasing hormone in patients with isolated adrenocorticotropin deficiency.
    Koide Y, Kimura S, Inoue S, Ikeda M, Uchida K, Ando J, Shimizu A, Oda K, Itakura M, Nabeshima I.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):329-35. PubMed ID: 3013917
    [Abstract] [Full Text] [Related]

  • 7. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T, Takahashi H, Ibayashi H, Nobunaga M.
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [Abstract] [Full Text] [Related]

  • 8. ACTH 1-17 and pituitary-adrenal function in human.
    Cavagnini F, Fossati R.
    Ric Clin Lab; 1984 Sep; 14(2):159-65. PubMed ID: 6091239
    [Abstract] [Full Text] [Related]

  • 9. Loperamide, an opiate analog, differently modifies the adrenocorticotropin responses to corticotropin-releasing hormone and lysine vasopressin in patients with Addison's disease.
    Bochicchio D, Ambrosi B, Faglia G.
    Neuroendocrinology; 1988 Dec; 48(6):611-4. PubMed ID: 2855105
    [Abstract] [Full Text] [Related]

  • 10. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR, Jackson RV, Kamilaris TC, Sheldon WR, Decherney GS, Island DP, Orth DN.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [Abstract] [Full Text] [Related]

  • 11. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS, DeBold CR, Jackson RV, Sheldon WR, Island DP, Orth DN.
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [Abstract] [Full Text] [Related]

  • 12. Loperamide modifies but does not block the corticotropin-releasing hormone-induced ACTH response in patients with Addison's disease.
    Ambrosi B, Bochicchio D, Colombo P, Ferrario R, Faglia G.
    Horm Metab Res Suppl; 1987 Aug; 16():74-5. PubMed ID: 2832297
    [Abstract] [Full Text] [Related]

  • 13. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
    Arvat E, Ramunni J, Maccagno B, Giordano R, Broglio F, Deghenghi R, Boscaro M, Ghigo E.
    Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
    [Abstract] [Full Text] [Related]

  • 14. Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.
    DeBold CR, DeCherney GS, Jackson RV, Sheldon WR, Alexander AN, Island DP, Rivier J, Vale W, Orth DN.
    J Clin Endocrinol Metab; 1983 Aug; 57(2):294-8. PubMed ID: 6306038
    [Abstract] [Full Text] [Related]

  • 15. GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal.
    Martins MR, Pinto AC, Brunner E, Silva MR, Lengyel AM.
    J Endocrinol Invest; 2003 Feb; 26(2):143-7. PubMed ID: 12739742
    [Abstract] [Full Text] [Related]

  • 16. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement.
    Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ.
    Clin Endocrinol (Oxf); 1981 May; 14(5):451-8. PubMed ID: 6273020
    [Abstract] [Full Text] [Related]

  • 17. Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease.
    Fehm HL, Voigt KH, Kummer G, Pfeiffer EF.
    J Clin Invest; 1979 Jul; 64(1):102-8. PubMed ID: 221540
    [Abstract] [Full Text] [Related]

  • 18. Plasma steroid responses to circadian-stage-specified injection of different doses of the ACTH analogue alsactide (ACTH 1-17) in healthy adult human males.
    Veglio F, Padoan M, Gambino M, Paccotti P, Terzolo M, Angeli A.
    Ric Clin Lab; 1988 Jul; 18(2-3):95-104. PubMed ID: 2850604
    [Abstract] [Full Text] [Related]

  • 19. No inhibition of corticotrophin (ACTH)-hypersecretion in adrenal insufficiency by somatostatin.
    Jara-Albarrán A, Bayort J, Caballero A, Eusebio R, García-Peris P, Toledano E, Pérez-Modrego S.
    Acta Endocrinol (Copenh); 1980 Sep; 95(1):71-4. PubMed ID: 6109417
    [Abstract] [Full Text] [Related]

  • 20. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H, Tamura T.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.